Insider plans sale of 10,000 common shares

An insider of GMED has filed a Form 144 notice to sell 10,000 shares of common stock through Raymond James & Associates on the NYSE.

Rhea-AI Filing Summary

An insider of GMED has filed a Form 144 notice to sell 10,000 shares of common stock through Raymond James & Associates on the NYSE. The shares have an aggregate market value of about $876,000 based on the figures disclosed.

The securities were acquired on 02/12/2026 via a cashless option exercise from the issuer, with the same date listed as the payment date. Over the prior three months, the same seller, Kelly Huller, sold 7,500 common shares for gross proceeds of about $674,620.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GMED's latest Form 144 filing disclose?

The filing discloses an insider’s intent to sell 10,000 GMED common shares. It outlines the planned broker, aggregate market value, acquisition method, recent prior sales, and confirms the filer’s representation about not possessing undisclosed material adverse information about the issuer.

How many GMED shares are planned for sale and at what value?

The insider plans to sell 10,000 GMED common shares with an aggregate market value of about $876,000. These shares are to be sold through Raymond James & Associates on the NYSE, according to the approximate sale date and exchange information disclosed.

How were the GMED shares in the Form 144 acquired?

The 10,000 GMED common shares were acquired on 02/12/2026 via a cashless option exercise from the issuer. The same date is listed as the payment date, with the nature of payment also described as a cashless option exercise in the filing.

What prior GMED share sales has the insider reported?

Over the past three months, the insider, Kelly Huller, sold 7,500 GMED common shares on 11/25/2025. Those shares generated gross proceeds of about $674,620, and this prior transaction is itemized in the section covering recent securities sales.

Which broker and exchange are involved in the planned GMED sale?

The insider intends to sell the GMED common shares through Raymond James & Associates, based in St. Petersburg, Florida. The filing lists the New York Stock Exchange (NYSE) as the securities exchange where the shares are expected to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 12:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768417
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	Huller Kelly
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	10000	876000.00	133839166	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Cashless Option Exercise	Issuer			10000	02/12/2026	Cashless Option Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kelly Huller 101 Eaglet Ln Schwenksville PA 19473	Common	11/25/2025	7500	674620.00

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Kelly G Huller
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)